Federal Register / Vol. 74, No. 111 / Thursday, June 11, 2009 / Notices 27805 

This notice is corrected as follows: On 

page 26704 first column, under 

SUMMARY, the Web site should read: 

http://wwwn.cdc.gov/publiccomments/. 

Dated: June 4, 2009. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–13694 Filed 6–10–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences; Initial Review 

Group Minority Programs Review, 

Subcommittee B. 

Date: July 9–10, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 

Contact Person: Rebecca H. Johnson, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18C, Bethesda, 

MD 20892. 301–594–2771. 

Johnsonrhnigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: June 4, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13757 Filed 6–10–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; MBRS SCORE. 

Date: July 9, 2009. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, Room 3AN12, 45 Center 

Drive, Bethesda, MD 20892 (Telephone 

Conference Call) 

Contact Person: Arthur L. Zachary, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN–12, Bethesda, 

MD 20892, (301) 594–2886, 

zacharya@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: June 4, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13758 Filed 6–10–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

Coordinating Center for Health 

Promotion (BSC, CCHP) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 8:30 a.m.–5 p.m., July 1, 

2009. 

Place: CDC, 1825 Century Boulevard, NE., 

Room 1042, Atlanta, Georgia 30345. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 75 people. 

Purpose: This BSC is charged with 

providing advice and guidance to the 

Secretary of Health and Human Services, the 

Director of CDC, and the Director of CCHP 

concerning strategies and goals for the 

programs and research within the National 

Center on Birth Defects and Developmental 

Disabilities and the National Center for 

Chronic Disease Prevention and Health 

Promotion. 

Matters To Be Discussed: The agenda will 

include a review and discussion of charges 

to the BSC Work Groups. The Work Group 

projects include strategic planning and 

procedures for future external peer review of 

programs in the National Center on Birth 

Defects and Developmental Disabilities, and 

the National Center for Chronic Disease 

Prevention and Health Promotion. The BSC 

will also discuss results of its review of the 

National Center for Chronic Disease 

Prevention and Health Promotion as an 

organizational unit at CDC. 

Providing Oral or Written Comments: It is 

the policy of the BSC, CCHP to provide a 

brief period for oral public comments. In 

general, each individual or group requesting 

to make an oral presentation will be limited 

to a total time of five minutes if time permits. 

Contact Person for Additional Information: 

Karen Steinberg, PhD, Senior Science Officer, 

Coordinating Center for Health Promotion, 

CDC, 4770 Buford Highway, NE., Mailstop E– 

70, Atlanta, Georgia 30341; telephone (404) 

498–6700; fax (404) 498–6880; or via e-mail 

at Karen.Steinberg@cdc.hhs.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

CDC and the Agency for Toxic Substances 

and Disease Registry. 

Dated: June 4, 2009. 

Lorenzo Falgiano, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E9–13692 Filed 6–10–09; 8:45 am] 

BILLING CODE 4163–18–P 


jlentini on PROD1PC65 with NOTICES